COMMUNIQUÉS West-GlobeNewswire
-
LB Pharmaceuticals to Participate in Upcoming September Investor Events
03/09/2026 -
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference
03/09/2026 -
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
03/09/2026 -
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026 -
Spyre Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2026 -
Lifecore Biomedical to Participate at CPHI Global Conference
03/09/2026 -
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
03/09/2026 -
L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.
03/09/2026 -
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
03/09/2026 -
Vivani Medical Announces Participation in Upcoming Investor Conferences
03/09/2026 -
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
03/09/2026 -
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
03/09/2026 -
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2026 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/09/2026 -
Monthly information on share capital and company voting rights
03/09/2026 -
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre
03/09/2026 -
DBV Technologies to Participate in Upcoming September Investor Conferences
03/09/2026 -
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/09/2026 -
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
03/09/2026
Pages